OTLK - Outlook Therapeutics falls on 1-for-20 reverse stock split
2024-03-12 15:14:22 ET
More on Outlook Therapeutics
- Outlook Therapeutics stock climbs 13% amid Chardan upgrade
- Outlook stock rallies on private placement, FDA study agreement
- Seeking Alpha’s Quant Rating on Outlook Therapeutics
- Historical earnings data for Outlook Therapeutics
- Financial information for Outlook Therapeutics